Lacayo, Norman J <br/><br/>
Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes.  [electronic resource] 

 -  Blood  Nov 2004 
 - 2646-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0006-4971 
<br/><br/><label>Standard No.: </label>10.1182/blood-2003-12-4449  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Benzamides<br/>Child<br/>Child, Preschool<br/>Cluster Analysis<br/>Core Binding Factor Alpha 3 Subunit<br/>DNA Helicases--analysis<br/>DNA-Binding Proteins--analysis<br/>Disease-Free Survival<br/>Gene Expression Profiling--methods<br/>Humans<br/>Imatinib Mesylate<br/>Infant<br/>Leukemia, Myeloid--diagnosis<br/>Mutation--genetics<br/>Nuclear Proteins--analysis<br/>Oligonucleotide Array Sequence Analysis<br/>Piperazines--therapeutic use<br/>Predictive Value of Tests<br/>Prognosis<br/>Proto-Oncogene Proteins--genetics<br/>Pyrimidines--therapeutic use<br/>Receptor Protein-Tyrosine Kinases--genetics<br/>Retrospective Studies<br/>Survival Analysis<br/>Transcription Factors--analysis<br/>X-linked Nuclear Protein<br/>fms-Like Tyrosine Kinase 3